血脂康对早期糖尿病肾病患者氧化应激的影响 |
| |
引用本文: | 魏娜,常万松,薛迪中,沈学飞. 血脂康对早期糖尿病肾病患者氧化应激的影响[J]. 中国全科医学, 2012, 15(18): 2085-2087 |
| |
作者姓名: | 魏娜 常万松 薛迪中 沈学飞 |
| |
作者单位: | 1. 武警河南省总队医院,河南省郑州市,450052 2. 中国人民解放军401医院崂山分院 |
| |
摘 要: | 目的探讨血脂康对早期糖尿病肾病(DN)患者氧化应激的影响。方法将56例早期DN患者随机分成血脂康组(28例)和安慰剂组(28例),另外选20例健康体检者作为正常对照组。DN患者均给予胰岛素控制血糖,血脂康组加用血脂康0.6 g/次,3次/d;安慰剂组加用外形相同含淀粉的胶囊,0.6 g/次,3次/d,均治疗12周。治疗前后观察3组受试者血脂〔三酰甘油(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、极低密度脂蛋白胆固醇(VLDL-C)、高密度脂蛋白胆固醇(HDL-C)〕水平及血清丙二醛(MDA)、超氧化物歧化酶(SOD)、尿清蛋白排泄率(UAER)的变化。结果与正常对照组比较,血脂康组和安慰剂组早期DN患者TG、TC、LDL-C、VLDL-C水平显著升高,HDL-C水平显著降低,血清SOD显著下降,MDA水平上升(P<0.05);血脂康治疗12周后,患者血清TG、TC、LDL-C、VLDL-C、MDA水平及UAER较治疗前显著下降,HDL-C水平及血清SOD活性较治疗前显著上升(P<0.05)。安慰剂处理前、后患者血脂、血清SOD、MDA及UAER间差异无统计学意义(P>0.05)。结论早期DN患者存在血脂紊乱和氧化应激,血脂康可调节早期DN患者血脂紊乱,并改善氧化应激,降低UAER,对早期DN治疗有益。
|
关 键 词: | 血脂康 糖尿病肾病 氧化性应激 |
Effect of Xuezhikang on Oxidative Stress in Early Diabetic Nephropathy |
| |
Affiliation: | WEI Na,CHANG Wan-song,XUE Di-zhong,et al.Armed Police Force Hospital of Henan,Zhengzhou 450052,China |
| |
Abstract: | Objective To study the effect of Xuezhikang on oxidative stress in patients with early diabetic nephropathy(DN).Methods 56 patients with early DN were randomly divided into Xuezhikang group(n=28) and placebo group(n=28).Besides,20 healthy physical examination people were selected as control group.Insulin was used in all patients.Xuezhikang group was given Xuezhikang 0.6 g each time and tid for 12 weeks.Placebo group was given starch capsule in the same shape of Xuezhikang 0.6 g each time and tid for 12 weeks.The levels of blood lipid(including TG,TC,LDL-C,VLDL-C,and HDL-C),SOD,MDA and UAER were observed in the three groups before and after treatment respectively.Results Compared with control group,TG,TC,LDL-C,VLDL-C and MDA of early DN patients were significantly increased,while HDL-C and SOD were significantly decreased(P<0.05).In Xuezhikang group,after 12 weeks treatment,TG,TC,LDL-C,VLDL-C,MDA and UAER were significantly decreased and HDL-C and SOD were significantly increased compared with those before treatment(P<0.05).After the treatment of placebo,serum levels of lipid profile,serum SOD,MDA and UAER showed no statistically difference compared with those before the treatment(P>0.05).Conclusion Patients with early DN are usually with dyslipidemia and oxidative stress.Xuezhikang is conducive to the treatment of early DN through regulating blood lipid disorders,improving oxidative stress and reducing UAER. |
| |
Keywords: | Xuezhikang Diabetic nephropathies Oxidative stress |
本文献已被 CNKI 万方数据 等数据库收录! |
|